Nexa News

A new drug, AZD-2025, has shown promising results in clinical trials for Alzheimer's disease, offering significant improvements in cognitive function and memory retention. The drug targets amyloid plaques and could be a game-changer in the treatment of this debilitating condition.

A new drug, NeuroGuard, has shown promising results in slowing down the progression of Alzheimer's disease, offering hope to millions of patients and their families. The clinical trials, published in June 2025, indicate significant improvements in cognitive function and quality of life.

Researchers at the Global Institute of Medical Innovation have developed CRISPR-X, a breakthrough gene editing technique that shows promise in treating Alzheimer's disease. Early clinical trials indicate significant improvements in cognitive function and memory.